Palantir rose after quarterly earnings blew past Wall Street estimates. Shares of Vertex Pharmaceuticals and Hims & Hers ...

In the latest quarter, Palantir posted adjusted earnings of 16 cents a share, whereas analysts were looking for 14 cents a ...

Where will Palantir stock be in 5 years? Analyze trends, predictions, and market factors to see the potential future of PLTR ...

Palantir's Q2 highlights surging AI adoption and 282% free cash flow growth. Despite premium valuation, PLTR's growth ...

Even bears acknowledge the success of Palantir's strategy. The company reported its second-quarter results after the market ...

Meta Platforms could be a $4.7 trillion company in five years, in which case it would be worth more than Palantir and Nvidia ...

Palantir is set to report quarterly earnings after the closing bell today, with traders expecting the best-performing S&P 500 ...

The data-software company's stock rose 5% premarket after it posted higher quarterly profit and revenue. It also [boosted its annual outlook]( ...

Palantir just reported its first-ever billion dollar revenue quarter. The stock's reaction so far is even more tepid than ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

In May, shares of Palantir fell 12% the day after its first quarter results as investors scrutinized the company's valuation ...

Palantir stock rose after quarterly earnings blew past Wall Street estimates. Shares of Vertex Pharmaceuticals and Hims & ...